SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : IMMD - ImmuDyne
IMMD 0.215-2.1%Jun 21 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: charles catlett who wrote (964)6/10/1997 9:00:00 AM
From: BI*RI   of 1249
 
And More:

Tuesday June 10 8:10 AM EDT

Company Press Release

ImmuDyne Inc. announces changes to board of directors


HOUSTON--(BW HealthWire)--June 10, 1997--ImmuDyne Inc. (OTC:BB - news) (IMMD), a Houston-based biotechnology company with proprietary technology for health enhancement products, recently announced that Andrew P. Calhoun, currently chairman of North American Water Company and Vignette Publications of Louisiana Inc., has joined the ImmuDyne board of directors and will be recommended by management for election at the next annual meeting of shareholders.

During this fiscal year, Ms. Fronie Shelton of Texas has resigned from the board for personal reasons. William Randall also resigned due to the demands of his rapidly growing business. James D. Wood, ImmuDyne's chairman and chief executive officer, commented, ``We thank both for their contributions to ImmuDyne and we continue to maintain a business relationship with Randall through Randall International, developers of skin care products for leading health spas internationally.''

ImmuDyne Inc. is traded on the NASD Automated Bulletin Board under the symbol IMMD. ImmuDyne Inc. is a Texas-based biotechnology company specializing in macrophage technology. It has proprietary technology relating to immune system stimulants for cosmetic, human nutritional, animal nutritional and aquacultural use. ImmuDyne Inc. maintains offices in Houston and Palo Alto, Calif. For more information on the company, contact Margaret Dreyfus, at 415/949-3864, or visit our website at www.immudyne.com .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext